Product Information
CHLOROQUINE PH 250 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $2.5396 per EA under NDC 64980017750. Its NADAC has been published 245 times since Nov 28, 2013.
FDA first approved this application on Jan 21, 2011. Its Orange Book therapeutic-equivalence code is AA.
Strength
250 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980017750
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLOROQUINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA091621FDA Approved
1/21/2011
TE Code
AA
On Market Since
7/1/2011
Pharmacological Classes
Price Statistics
The NADAC for CHLOROQUINE PH 250 MG TABLET has been published 245 times since Nov 28, 2013, and over the history we have for it it has risen 193.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5396 per EA |
|---|---|
| All-time high | $2.8586 (Aug 13, 2025) |
| All-time low | $0.8668 (Nov 28, 2013) |
| 52-week high | $2.7222 |
| 52-week low | $2.2329 |
| Median price | $2.0182 |
| Average price | $1.7061 |
| Largest weekly change | +137.0% (May 22, 2024) |
| Weeks tracked | 245 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Chloroquine Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chloroquine Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimalarial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLOROQUINE PH 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLOROQUINE PH 250 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $2.5396 per EA (NDC 64980017750), effective Sep 30, 2026.
How has the price of CHLOROQUINE PH 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLOROQUINE PH 250 MG TABLET has risen 193.0%. It has been tracked across 245 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CHLOROQUINE PH 250 MG TABLET?
Since Nov 28, 2013, the NADAC for CHLOROQUINE PH 250 MG TABLET has ranged from a low of $0.8668 (Nov 28, 2013) to a high of $2.8586 (Aug 13, 2025), with a median of $2.0182 per EA.
Are there cheaper alternatives to CHLOROQUINE PH 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CHLOROQUINE PH 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLOROQUINE PH 250 MG TABLET?
CHLOROQUINE PH 250 MG TABLET (NDC 64980017750) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.